This audio article is from VisualFieldTest.com. Read the full article here: https://visualfieldtest.com/en/the-copper-peptide-and-the-optic-nerve-a-deep-look-at-ghk-cu-oxidative-stress-and-glaucoma Test your visual field online: https://visualfieldtest.com Support the show so new episodes keep coming: https://www.buzzsprout.com/2563091/support Excerpt: Introduction Glaucoma is a group of eye diseases where nerve cells in the retina (retinal ganglion cells, or RGCs) slowly die, causing vision loss (). In most cases, high intraocular pressure (IOP, the fluid pressure inside the eye) is a major risk factor (). Treatments currently focus on lowering IOP, but this may not always stop nerve loss (). Indeed, some patients continue to worsen despite well-controlled pressure, suggesting other factors are at work () (). Glaucoma is now understood as a multifactorial optic neuropathy – age, blood flow, immune signals, cellular stress and genetics all play roles () (). In simple terms, glaucoma damages the optic nerve (the bundle of RGC axons connecting the eye to the brain) over time, often starting in mid-life or later. While lowering eye pressure is the only proven therapy now (), scientists are looking at other pathways because vision loss can continue from aging, reduced blood supply, oxidative damage, inflammation, and other cell-level problems () (). Plain-language summary: Glaucoma is a complex disease: it usually involves high eye pressure, but also aging, blood flow problems, and damage to retinal nerve cells. Treatments lower pressure, but they don’t always protect these cells fully. What is GHK-Cu? GHK-Cu stands for a small peptide (three amino acids: glycine-histidine-lysine) bound to a copper ion. It is a natural molecule found in the body (in blood plasma and wound fluid) () (). Doctors first discovered GHK in the 1970s as a “growth factor” in human plasma that could boost tissue repair (). GHK-Cu is much studied in dermatology and wound healing: it stimulates collagen and new tissue growth in experiments () (). Its levels normally decline with age (), and people have become interested in it for its anti-aging and repair signals. Overall, GHK-Cu is considered a normal human peptide, often cited as safe and well-tolerated (). It can be applied to the skin or taken systemically in research, but there is no approved medical use yet. In this article, “systemic effects” of GHK-Cu means effects throughout the body (bloodstream, organs), not just local skin or eye treatments. Plain-language summary: GHK-Cu is a naturally occurring protein fragment that carries copper. It is known to help wounds heal and may influence genes. People study it for anti-aging, but it is not a proven medicine for anything. Overlapping Biology of GHK-Cu and Glaucoma Oxidative Stress Oxidative stress is the damage that happens when harmful oxygen molecules (free radicals) build up and overwhelm the body’s defenses. It is like cellular “rust.” High levels of oxidative stress are found in glaucoma and other nerve diseases () (). Retinal ganglion cells have very high energy needs and rich fatty membranes, making them especially vulnerable to free radicals (). Research notes that when oxidative damage occurs (for example from high pressure or aging), it can trigger inflammation and nerve injury in the optic nerve () (). GHK-Cu has multiple antioxidant actions in lab studies. In wound experiments, GHK-Cu treatment boosted levels of antioxidant enzymes and molecules like glutathione and vitamin C (). It also directly neutralizes toxic lipid-byproducts. For example, GHK-Cu can bind and inactivate harmful breakdown products of fats (like acrolein and 4-HNE) that would otherwise damage cells (). In cultured cells, GHK alone (with or without copper) has been shown to reduce reactive oxygen species (). Computer analyses suggest GHK-Cu turns on many genes for antioxidant defense. For instance, one review notes GHK-Cu helps support enzymes like superoxide dismutase (SOD) and modulates iron levels to fight oxidative stress (). All together, these findings suggest that GHK-Cu could, in principle, boost the body’s antioxidant responses. However, antioxidant effects in cell or skin models do not guarantee protection of eye nerves. The eye has barriers and specialized chemistry. Simply taking an “antioxidant peptide” does not automatically cure glaucoma. Also, the body’s redox balance is complex – you can’t assume more antioxidants always help. For example, some large clinical trials of generic antioxidants in glaucoma have not clearly stopped progression (). Summary: GHK-Cu activates many antioxidant pathways and so might, in theory, help cells fight “rust.” But convincing evidence that it would specifically shield optic nerve cells in glaucoma is lacking. Mitochondrial Function Mitochondria are the cell’s energy factories. They use oxygen to produce ATP, the fuel cells need. Neurons like RGCs have huge energy demands, so healthy mitochondria are critical for their survival. Numerous studies link glaucoma to mitochondrial dysfunction (). In fact, glaucoma risk rises with age and with failing mitochondria – both and RGCs rely heavily on mitochondrial energy (). Conditions that hit mitochondria (low oxygen, metabolic stress) can trigger RGC damage in glaucoma. For example, in glaucoma models, high pressure or oxidative stress can impair mitochondrial function in RGCs and even form harmful protein clumps () (). In human optic nerve diseases like Leber’s hereditary optic neuropathy, a pure mitochondrial disorder, only the RGCs die (), highlighting this vulnerability. What about GHK-Cu? There’s no direct evidence on GHK-Cu and mitochondria in retinal cells. However, we can note some related points. Copper (delivered by GHK-Cu) is a cofactor for key mitochondrial enzymes. In particular, cytochrome c oxidase (complex IV of the electron transport chain) requires copper (). Thus, if GHK safely delivers copper, it might support mitochondrial energy production by supplying this element. (But this is purely hypothetical – it’s not proven that orally or topically given GHK-Cu ends up in mitochondria of RGCs.) Another idea is that by reducing inflammation or oxidative damage (as above), GHK-Cu could indirectly protect mitochondria. For now, this is speculative: we simply don’t have experiments showing GHK-Cu restores mitochondrial function in glaucoma. Plain-language summary: Retinal neurons need a lot of energy. In glaucoma, energy factories (mitochondria) in these cells can fail (). GHK-Cu may deliver copper needed by those factories (), but nobody knows if it actually helps RGCs make energy. There’s no direct proof GHK-Cu fixes mitochondrial issues in glaucoma. Neuroinflammation Glaucoma is increasingly seen as a brain-like neurodegenerative disease, with chronic inflammation in the retina and optic nerve. When RGCs are stressed or injured (by pressure, lack of blood, etc.), they release danger signals that activate immune cells (microglia and astrocytes) in the eye (). This neuroinflammatory response can help at first, but if it goes on too long it can harm RGCs and neighboring cells. In animal models of glaucoma, blocking certain inflammatory pathways (like IL-1β or TNFα signaling) protects RGCs (). Postmortem studies of human glaucoma eyes also show signs of chronic inflammation: activated inflammasomes and elevated inflammatory markers have been found in the optic nerve and retina () (). GHK-Cu has reported anti-inflammatory effects in other contexts. Wound studies noted that GHK-Cu treatment not only boosted antioxidants but also dampened inflammation (). GHK-Cu (and even GHK peptide alone) can lower pro-inflammatory molecules in skin cells after UV damage and in lung models of smoke injury. In cell studies, GHK orphaned deleterious oxidized lipids and prevented them from triggering inflammation (). In plain words, GHK-Cu seems to smooth out overactive immune responses in tissues like skin and lung. But it’s a big leap to assume the same would happen in glaucoma. The eye’s immune environment is very specialized. We have no experiments on GHK-Cu reducing microglial activation or retinal cytokines. Still, as a hypothesis: if GHK-Cu reduced chronic inflammation systemically, it could help protect nerves. This idea overlaps with general neuroprotection research (many studies look for anti-inflammatory treatments in glaucoma), but nothing specific links GHK-Cu to ocular neuroinflammation yet. Plain-language summary: Chronic inflammation in the eye damages nerve cells in glaucoma (). GHK-Cu is known to reduce inflammation in skin and other tissues (), so it might help calm the eye’s immune response – but this is only speculation because we have no direct data for glaucoma. Copper Biology Copper is a tricky element in biology: essential in trace amounts but toxic if unbalanced. It is an important cofactor for enzymes that protect cells. For example, copper is needed by superoxide dismutase (SOD) and ceruloplasmin – enzymes that break down reactive oxygen species (). Copper also helps regulate blood vessel growth and connective tissue enzymes. In fact, a deficiency of copper can impair normal repair and antioxidant defenses. However, free copper ions can trigger more oxidative stress through Fenton chemistry, so the body normally keeps copper tightly bound to carrier proteins. GHK-Cu is interesting because it tightly binds copper in a small peptide complex. In theory, GHK Support the show
